恒生沪深港创新药精选50指数 (HSSSHID.hk)编制方案单张 | ( 市盈率 39.88 | 市净率 2.61 | 市销率 1.68 | 股息率 1.34% )·市值加权 | 发布时间2020-03-01样本数50前十大权重55.19%类型策略收盘点位5,581.60(-0.26%, 13.52亿港币)市值2.36万亿港币发布以来年化涨跌幅-4.54% |
| 恒生沪深港创新药精选50指数追踪首五十只研究及发展投入较高且动量表现较好并于沪深港上市的创新药相关股票之表现。®基础数据源自香港指数公司。指数估值数据计算说明文档指数财务数据计算说明文档 | |||||
| 备注 (0) | 双击编辑备注 | ||||
恒生沪深港创新药精选50指数(HSSSHID) - 收益率历史月度涨跌幅列表
最后更新于：2024-11-21
| 年 | 1月 | 2月 | 3月 | 4月 | 5月 | 6月 | 7月 | 8月 | 9月 | 10月 | 11月 | 12月 | 年度涨跌幅 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 上涨概率 / 上涨中位数 | 50.00% / -5.68% | 50.00% / -1.68% | 20.00% / -1.67% | 60.00% / 0.56% | 40.00% / -1.87% | 60.00% / 2.90% | 60.00% / 4.16% | 0.00% / -1.88% | 60.00% / 3.39% | 60.00% / 1.30% | 60.00% / 1.85% | 50.00% / -4.15% | 20.00% / -9.64% |
| 2024 | -22.09% | 12.24% | -6.63% | -0.02% | -5.81% | -5.96% | 6.85% | -0.71% | 21.99% | -5.20% | 1.85% | -- | -9.64% |
| 2023 | 5.86% | -5.03% | -6.77% | 0.56% | -6.16% | -5.47% | 4.16% | -1.88% | 3.39% | 4.31% | -2.39% | -9.11% | -18.25% |
| 2022 | -14.30% | 0.55% | 3.20% | -12.13% | -1.87% | 11.76% | -6.51% | -3.56% | -12.99% | 5.29% | 13.12% | 0.14% | -19.81% |
| 2021 | 2.94% | -3.91% | -0.77% | 10.46% | 5.24% | 2.90% | -7.78% | -8.79% | 5.35% | -6.33% | 2.30% | -8.44% | -8.71% |
| 2020 | -- | -- | -1.67% | 8.91% | 4.12% | 18.84% | 12.27% | -0.20% | -10.28% | 1.30% | -5.06% | 15.90% | 48.48% |
